-
1
-
2by I. I. Snegireva, E. Yu. Pasternak, K. E. Zatolochina, M. A. Darmostukova, R. N. Alyautdin, V. A. Polivanov“...Problems of interchangeability of systemic interferons for treatment of multiple sclerosis...”
Published 2018-02-01
Get full text
Article -
3by A. V. Philippova, A. S. Kolbin, E. V. Verbitskaya, S. V. Glagolev, V. A. Polivanov“... systemic characteristic of safety profile of monoclonal antibodies used in rheumatology, based...”
Published 2019-10-01
Get full text
Article -
4by N. V. Molchan, Yu. A. Smirnova, N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, V. A. Polivanov“... information system of Roszdravnadzor from 2008 to 2018. Results: 3403 adverse reactions that occurred in 2083...”
Published 2019-06-01
Get full text
Article -
5by B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, A. E. Krasheninnikov“... system of Pharmacovigilance» and subsequent evaluation of the Roszdravnadzor the information...”
Published 2018-03-01
Get full text
Article -
6by A. R. Titova, E. Y. Pasternak, I. L. Asetskaya, S. K. Zyryanov, V. A. Polivanov, R. N. Alyautdin, B. K. Romanov“.... In addition to evaluating the overall structure of serious AR and their distribution to system organ classes...”
Published 2018-02-01
Get full text
Article
